Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: A feasible surgical strategy

Annals of Surgery

Volumn 254, Issue 6, 2011, Pages 1022-1027

  Scholten, Anouk ^a   Valk, Gerlof D ^a   Ulfman, Dionne ^a   Borel, Rinkes Inne H M ^a   Vriens, Menno R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CORTICOSTEROID; NORMETADRENALIN; STEROID;

ADRENAL CORTEX INSUFFICIENCY; ADRENALECTOMY; ADULT; ARTICLE; CATECHOLAMINE URINE LEVEL; FEMALE; FOLLOW UP; HEADACHE; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SPLEEN RUPTURE; SURVIVAL; TUMOR VOLUME; UNIVERSITY HOSPITAL;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; COHORT STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEOPLASM RECURRENCE, LOCAL; PHEOCHROMOCYTOMA; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 81855224647     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318237480c     Document Type: Article

References (37)

1. Howe JR, Norton JA, Wells SA, Jr. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of longterm follow-up. Surgery. 1993;114:1070-1077.
2. Carney JA, Go VL, Sizemore GW, et al. Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b. N Engl J Med. 1976;295:1287-1291.
3. Lips KJ, Van der Sluys Veer J, Struyvenberg A, et al. Bilateral occurrence of pheochromocytoma in patientswith themultiple endocrine neoplasia syndrome type 2A (Sipple's syndrome). Am J Med. 1981;70:1051-1060.
4. Raue F, Frank-RaueKUpdate multiple endocrine neoplasia type 2. FamCancer 2010;9:449-457
5. van Heerden JA, Sizemore GW, Carney JA, et al. Surgical management of the adrenal glands in the multiple endocrine neoplasia type 2 syndrome. World J Surg. 1984;8:612.
6. Modigliani E, Vasen HM, Raue K, et al. Pheochromocytoma in multiple endocrine neoplasia type 2: European Study. J Intern Med. 1995;238: 236-237.
7. de Graaf JS, Nieweg OE, Oosterkamp AE, et al. Results of 25-year pheochromocytoma treatment in the Groningen Academic Hospital. Ned Tijdschr Geneeskd. 1997;141:148-151.
8. Tibblin S, Dymling JF, Ingemansson S, et al. Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA. World J Surg. 1983;7:201-208.
9. de Graaf JS, Dullaart RP, Zwierstra RP Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2-a plea to conserve adrenal function. Eur J Surg. 1999;165:843-846.
10. Telenius-Berg M, Ponder MA, Berg B, et al. Quality of life after bilateral adrenalectomy in MEN2. Henry Ford Hosp Med J. 1989;37:160-163.
11. Reisch N, Arlt W Fine tuning for quality of life: 21st century approach to treatment of Addison's disease. Endocrinol Metab Clin N Am. 2009;38:407-418.
12. Hahner S, Allolio B Therapeutic management of adrenal insufficiency. Best Pract Res Clin Endocrinol Metabol. 2009;23:167-179.
13. Lairmore TC, Ball DW, Baylin SB, et al. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg. 1993;217:595-603.
14. Lee JE, Curley SA, Gagel RF, et al. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery. 1996;120:1064-1070. Discussion 1070-1071.
15. Iihara M, Suzuki R, Kawamata A, et al. Adrenal-preserving laparoscopic surgery in selected patients with bilateral adrenal tumors. Surgery. 2003;134:1066-1072. Discussion 1072-1073.
16. Yip L, Cote GJ, Shapiro SE, et al. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg. 2003;138:409-416. Discussion 416.
17. Asari R, Scheuba C, Kaczirek K, et al. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Arch Surg. 2006;141:1199-1205.
18. Takami H, Ikeda Y, Takayama J, et al. Adrenal-sparing adrenalectomy in hereditary bilateral phaeochromocytoma. ANZ J Surg. 2001;71:623-624.
19. Edström E, Gröndal S, Norström F, et al. Long-term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa. Eur J Surg. 1999;165:431-435.
20. Brauckhoff M, Gimm O, Brauckhoff K, et al. Repeat adrenocortical-sparing adrenalectomy for recurrent hereditary pheochromocytoma. Surg Today. 2004;34:251-255.
21. Mugiya S, Suzuki K, Saisu K, et al. Unilateral laparoscopic adrenalectomy followed by contralateral retroperitoneoscopic partial adrenalectomy in a patient with multiple endocrine neoplasia type 2a syndrome. J Endourol. 1999;13:99-104. Discussion 104-106.
22. Porpiglia F, Destefanis P, Bovio S, et al. Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA. Horm Res. 2002;57:197-199.
23. Walz MK, Peitgen K, Neumann HP, et al. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg. 2002;26:1005-1012.
24. de Graaf JS, Lips CJ, Rutter JE, et al. Subtotal adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2A. Eur J Surg. 1999;165:535-538.
25. Goldstein RE, O'Neill JA, Jr, Holcomb GW, III, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229:755-764. Discussion 764-766.
26. Neumann HPH, Reincke M, Bender BU, et al. Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma. J Clin Endocrinol Metab. 1999;84:2608-2610.
27. Jansson S, Khorram-Manesh A, Nilsson O, et al. Treatment of bilateral pheochromocytoma and adrenal medullary hyperplasia. Ann N Y Acad Sci. 2006;1073:429-435.
28. Yip L, Lee JE, Shapiro SE, et al. Surgical management of hereditary pheochromocytoma. J Am Coll Surg. 2004;198:525-534. Discussion 534-535.
29. Inabnet WB, Caragliano P, Pertsemlidis D Pheochromocytoma: inherited associations, bilaterality and cortex preservation. Surgery. 2000;128:1007-1011.
30. Schreinemakers JM, Kiela GJ, Valk GD, et al. Retroperitoneal endoscopic adrenalectomy is safe and effective. Br J Surg. 2010;97:1667-1672.
31. Evans DB, Lee JE, Merell RC, et al. Adrenal medullary disease in multiple endocrine neoplasia type. Endocrinol Metab Clin North Am. 1994;23: 167-176.
32. Goretzki PE, Simon D, Dotzenrath C, et al. Surgery for pheochromocytoma in MEN II patients: a radical versus a limited approach. Acta Chir, Aus. 1996;28:296-301.
33. Casanova S, Rosenberg-Bourgin M, Farkas D, et al. Pheochromocytoma in multiple endocrine neoplasia type 2A: a survey of 100 cases. Clin Endocrinol. 1993;38:531-537.
34. Tibblin S, Dymling JF, Ingemansson S, et al. Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA. World J Surg. 1983;7:201-208.
35. Li LM, Fitzgerald PA, Price DC, et al. Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy. Surgery. 2001;130:1072-1077.
36. Baghai M, Thompson GB, Young WF, Jr, et al. Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg. 2002;137:682-689.
37. Nambirajan T, Janetschek G Laparoscopic partial adrenalectomy. Minim Invasive Ther Allied Technol. 2005;14:71-77.